Establishment of iPS cell line (KLRMMEi002-A) by reprogramming peripheral blood mononuclear cells from a patient with USH2A-associated Usher syndrome

Researchers in China successfully created an induced-pluripotent stem (iPS) cell line using immune cells from the blood of a patient with Usher syndrome type 2A.

What this means for Usher syndrome: The ability to reliably produce cells in a lab with mutations in USH2A allows scientists to study the disease and test some therapies. The use of patient-derived stem cells provides an alternative to animal models for the study of pathogenic mechanisms.

Link to original article